Bruush Competitors

Delisted . USA . 
Stock . Bruush Oral Care
BRSHDelisted Stock  USD 0.0005  0.0001  16.67%   
Bruush Oral Care competes with European Wax, Edgewell Personal, Inter Parfums, Henkel AG, and Yoshitsu; as well as few others. The company conducts business under Personal Care Products sector and is part of Consumer Staples industry. Analyzing Bruush Oral competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Bruush Oral to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Bruush Oral competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bruush Oral's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.000649.20
Details
Intrinsic
Valuation
LowRealHigh
0.000.000549.20
Details
Naive
Forecast
LowNextHigh
0.00030.0149.21
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.00020.00080
Details

Bruush Oral Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bruush Oral and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Bruush and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bruush Oral Care does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
NTCO
+ 0.86
HELKF
TKLF
+ 0.61
EPC
HELKF
+ 0.54
EWCZ
NTCO
+ 0.45
EWCZ
YSG
+ 0.32
IPAR
YSG
+ 0.21
NTCO
  
High negative correlations   
TKLF
- 0.82
NTCO
HELKF
- 0.79
EPC
TKLF
- 0.76
HELKF
NTCO
- 0.73
EPC
TKLF
- 0.63
EWCZ
YSG
- 0.43
EPC

Risk-Adjusted Indicators

There is a big difference between Bruush Stock performing well and Bruush Oral Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bruush Oral's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Bruush Oral Competitive Analysis

The better you understand Bruush Oral competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bruush Oral's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bruush Oral's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BRSH EWCZ EPC IPAR HELKF NTCO TKLF YSG
 16.67 
 0.0005 
Bruush
 2.42 
 8.04 
European
 0.17 
 36.41 
Edgewell
 1.70 
 125.88 
Inter
 0.00 
 82.75 
Henkel
 3.30 
 7.52 
Natura
 4.35 
 0.44 
Yoshitsu
 0.77 
 3.87 
Yatsen
Market Volatility
(90 Days Market Risk)
Out of control
Moderately volatile
Very steady
Very steady
Very steady
Very steady
Out of control
Risky
Market Performance
(90 Days Performance)
OK
Insignificant
Very Weak
Very Weak
Modest
Very Weak
Very Weak
Insignificant
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Low
Low
Low
Low
Dangerous
Low
Above Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Under Valued
Under Valued
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Buy
Buy
Strong Buy
Not Available
Not Available
Strong Sell
Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Strong Hold
Sell
Sell
Not Rated
Strong Sell
Strong Sell
Current Ratio
0.21 X
2.57 X
1.62 X
2.89 X
1.04 X
1.30 X
1.83 X
5.47 X
Net Asset
1.19 M
735.73 M
3.74 B
1.37 B
32.67 B
54.69 B
142.92 M
5.01 B
Profit Margin
(2.57) %
0.06 %
0.05 %
0.11 %
0.05 %
0.14 %
0.04 %
(0.27) %
EBITDA
(10.49 M)
65.03 M
331.8 M
268.71 M
3.18 B
2.2 B
8.68 M
(9.09 M)
Operating Margin
(5.29) %
0.24 %
0.14 %
0.25 %
0.1 %
(0.01) %
0.04 %
(0.17) %
Current Valuation
2.51 M
700.07 M
2.91 B
4.3 B
31.04 B
10.44 B
81.92 M
185.46 M
Price To Book
N/A
4.42 X
1.14 X
5.73 X
1.37 X
0.79 X
0.06 X
0.74 X
Retained Earnings
(26.39 M)
(109.51 M)
1.01 B
693.85 M
13.73 B
(1.99 B)
21.07 M
(7.35 B)
Current Asset
N/A
N/A
1.45 B
468.76 M
8.96 B
9.39 B
N/A
N/A
Five Year Return
N/A
N/A
N/A
1.49 %
N/A
N/A
N/A
N/A
Beta
N/A
1.25
0.86
1.17
0.56
1.27
0.029
-2.82
Number Of Employees
11
120
6.8 K
607
51.8 K
16
140
1.5 K
Shares Outstanding
100.97 M
47.77 M
49.31 M
32.03 M
259.8 M
690.42 M
4.22 M
70.43 M
Cash Flow From Operations
(12.59 M)
55.6 M
216.1 M
105.77 M
2.14 B
(1.37 B)
1.9 M
(107.44 M)
Annual Yield
N/A
N/A
0.02 %
0.02 %
0.03 %
0.04 %
N/A
N/A
Total Debt
2.59 M
380.39 M
1.38 B
192.37 M
1.54 B
16.86 B
65.07 M
113.23 M
Return On Equity
N/A
0.14
0.0765
0.2
0.0581
-0.0775
0.23
-0.2
Z Score
N/A
N/A
N/A
N/A
11.4
N/A
N/A
N/A
Return On Asset
-5.77
0.0428
0.0439
0.11
0.0406
0.0118
0.0223
-0.0844
Number Of Shares Shorted
2.22 M
2.36 M
2.53 M
598.36 K
N/A
788.05 K
350.93 K
835.34 K
Book Value Per Share
(10.12) X
1.78 X
31.92 X
24.31 X
46.98 X
20.30 X
0.85 X
37.65 X
Current Liabilities
N/A
N/A
868.2 M
131.08 M
8.01 B
7.62 B
N/A
N/A
Total Asset
1.19 M
735.73 M
3.74 B
1.37 B
32.67 B
54.69 B
142.92 M
5.01 B
Short Ratio
0.05 X
4.52 X
5.75 X
3.83 X
N/A
0.69 X
3.60 X
3.09 X
Debt To Equity
N/A
2.84 %
0.96 %
0.22 %
0.18 %
0.68 %
1.45 %
0.05 %
Target Price
N/A
8.69
42.0
164.75
N/A
7.71
N/A
4.71
Last Dividend Paid
N/A
N/A
0.6
0.63
1.85
N/A
N/A
N/A
Shares Owned By Institutions
12.96 %
99.27 %
95.66 %
58.55 %
13.00 %
4.18 %
2.66 %
17.02 %
Market Capitalization
8.68 M
463.64 M
1.79 B
4.03 B
30.03 B
4.63 B
1.93 M
388.78 M
Price To Earnings To Growth
N/A
0.32 X
2.39 X
2.73 X
1.86 X
(16.12) X
N/A
N/A
Price To Earning
N/A
N/A
35.85 X
75.69 X
17.11 X
31.99 X
14.67 X
N/A
Price To Sales
2.97 X
2.10 X
0.79 X
3.01 X
1.39 X
0.13 X
0.01 X
0.12 X
Net Income
(8.77 M)
8.93 M
112.9 M
152.65 M
1.63 B
4.75 B
7.44 M
(750.23 M)
Earnings Per Share
(14.67) X
0.26 X
2.37 X
4.67 X
2.81 X
(0.58) X
0.20 X
(1.14) X
Shares Owned By Insiders
17.35 %
0.73 %
5.34 %
43.65 %
61.80 %
N/A
73.39 %
N/A
Revenue
2.63 M
221.02 M
2.25 B
1.32 B
20.07 B
34.84 B
194.68 M
3.41 B
Working Capital
(1.41 M)
57.67 M
428.7 M
514.28 M
951 M
2.78 B
4.35 B
2.34 B
Cash And Equivalents
N/A
31.19 M
216.4 M
195.88 M
1.92 B
4.28 B
17.67 M
3.14 B
Cash Per Share
N/A
0.79 X
3.50 X
6.15 X
4.44 X
6.23 X
0.49 X
5.06 X
Gross Profit
1.76 M
148.12 M
937.9 M
607.42 M
9.07 B
23.19 B
39.05 M
2.52 B
Day Typical Price
6.0E-4
8.01
36.27
129.47
82.75
7.44
0.44
3.89
Accumulation Distribution
0.29
28697.11
37353.6
28275.21
N/A
0.0384
40165.83
14466.58
Market Facilitation Index
2.0E-4
0.0
0.0
0.0
N/A
0.29
N/A
0.0
Daily Balance Of Power
(0.50)
0.5
0.0234
(0.17)
0.0
0.8276
(0.67)
(0.14)
Period Momentum Indicator
(0.0001)
0.19
0.06
(2.18)
N/A
0.24
(0.02)
(0.03)
Rate Of Daily Change
0.83
1.02
1.0
0.98
1.0
1.03
0.96
0.99
Day Median Price
6.0E-4
7.99
36.2
131.26
82.75
7.4
0.45
3.9
Price Action Indicator
(0.0001)
0.14
0.24
(6.47)
N/A
0.23
(0.01)
(0.04)
Relative Strength Index
23.47
70.14
54.0
53.72
61.12
68.54
38.8
55.92
Coefficient Of Variation
1909.1
1966.12
(4,634)
(3,148)
1308.53
342.48
(2,018)
1992.45
Mean Deviation
30.88
2.66
1.1
1.43
0.4256
2.47
3.47
2.42
Jensen Alpha
2.79
0.0618
(0.19)
(0.25)
0.1045
0.8558
(0.16)
0.0369
Total Risk Alpha
(10.74)
(0.80)
(0.37)
(0.46)
(0.19)
0.2158
(1.36)
(0.56)
Sortino Ratio
0.0855
0.0076
N/A
N/A
N/A
0.3017
N/A
(0.01)
Downside Variance
1293.12
35.86
N/A
N/A
N/A
6.94
N/A
10.24
Standard Deviation
62.24
4.55
1.45
1.74
1.2
3.36
4.91
3.16
Kurtosis
25.57
19.5
0.7943
(0.45)
12.08
3.91
2.4
0.11
Potential Upside
90.91
5.08
2.17
2.23
1.64
5.72
6.9
5.76
Treynor Ratio
1.23
0.2438
(0.05)
(0.06)
(0.63)
1.48
0.4717
0.2337
Maximum Drawdown
465.38
29.96
7.34
7.9
9.73
20.38
27.36
13.97
Variance
3874.29
20.73
2.11
3.02
1.44
11.28
24.09
10.01
Market Risk Adjusted Performance
1.24
0.2538
(0.04)
(0.05)
(0.62)
1.49
0.4817
0.2437
Risk Adjusted Performance
0.0508
0.0481
(0.01)
(0.02)
0.0633
0.236
(0.03)
0.0468
Skewness
4.26
(3.17)
(0.51)
(0.22)
0.9405
1.19
(0.49)
0.1155
Semi Deviation
29.46
5.65
N/A
N/A
N/A
1.76
N/A
2.92
Information Ratio
0.0494
0.0101
(0.15)
(0.14)
(0.08)
0.2367
(0.09)
(0.01)
Value At Risk
(58.43)
(5.61)
(2.72)
(3.02)
N/A
(4.03)
(8.77)
(4.79)
Expected Short fall
(54.11)
(2.54)
N/A
N/A
N/A
(3.00)
N/A
(2.65)
Downside Deviation
35.96
5.99
N/A
N/A
N/A
2.64
N/A
3.2
Semi Variance
868.15
31.91
N/A
N/A
N/A
3.11
N/A
8.52

Bruush Oral Competition Performance Charts

Five steps to successful analysis of Bruush Oral Competition

Bruush Oral's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Bruush Oral Care in relation to its competition. Bruush Oral's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Bruush Oral in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Bruush Oral's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Bruush Oral Care, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Bruush Oral position

In addition to having Bruush Oral in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Large & Mid Caps ETFs Thematic Idea Now

Large & Mid Caps ETFs
Large & Mid Caps ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Large & Mid Caps ETFs theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large & Mid Caps ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Bruush Stock

If you are still planning to invest in Bruush Oral Care check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bruush Oral's history and understand the potential risks before investing.
Global Correlations
Find global opportunities by holding instruments from different markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY